Methylation and demethylation of intermediates selenide and methylselenol in the metabolism of selenium.
All nutritional selenium sources are transformed into the assumed common intermediate selenide for the syntheses of selenoproteins for utilization and/or of selenosugar for excretion. Methylselenol [monomethylselenide, MMSe] is the assumed intermediate leading to other methylated metabolites, dimethylselenide (DMSe) and trimethylselenonium (TMSe) for excretion, and also to the intermediate selenide from methylselenocysteine and methylseleninic acid (MSA). Here, related methylation and demethylation reactions were studied in vitro by providing chemically reactive starting substrates (76Se-selenide, 77Se-MMSe and 82Se-DMSe) which were prepared in situ by the reduction of the corresponding labeled proximate precursors (76Se-selenite, 77Se-MSA and 82Se-dimethylselenoxide (DMSeO), respectively) with glutathione, the three substrates being incubated simultaneously in rat organ supernatants and homogenates. The resulting chemically labile reaction products were detected simultaneously by speciation analysis with HPLC-ICP-MS after converting the products and un-reacted substrates to the corresponding oxidized derivatives (selenite, MSA and DMSeO). The time-related changes in selenium isotope profiles showed that demethylation of MMSe to selenide was efficient but that of DMSe to MMSe was negligible, whereas methylation of selenide to MMSe, and MMSe to DMSe were efficient, and that of DMSe to TMSe occurred less efficiently. The present methylation and demethylation reactions on equilibrium between selenide, MMSe and DMSe without producing selenosugar and selenoproteins indicated that DMSe rather than TMSe is produced as the end product, suggesting that DMSe is to be excreted more abundantly than TMSe. Organ-dependent differences in the methylation and demethylation reactions were characterized for the liver, kidney and lung.
Ohta
Yuki
Y
Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo, Chiba 260-8675, Japan.
Suzuki
Kazuo T
KT
D000818:Animals; D005978:Glutathione / Q000378:metabolism; D066298:In Vitro Techniques; D007554:Isotopes; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D008297:Male; D000432:Methanol / Q000031:analogs & derivatives; D008745:Methylation; D009928:Organ Specificity; D016566:Organoselenium Compounds / Q000378:metabolism*; D010087:Oxides / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D020887:Selenious Acid / Q000378:metabolism; D012643:Selenium; D018036:Selenium Compounds / Q000378:metabolism*
D007554:Isotopes; D016566:Organoselenium Compounds; D010087:Oxides; D018036:Selenium Compounds; C007481:dimethylselenoxide; C019003:methaneselenol; C008493:methylselenic acid; D020887:Selenious Acid; D005978:Glutathione; D012643:Selenium; C026372:hydrogen selenide; D000432:Methanol; C013503:dimethylselenide